MarketCap
Facebook
X
Telegram
Harrow Health Shares | HROW
Annual Shares Harrow Health
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 36.8 M | 35.7 M | 32.6 M | 27.5 M | 26.8 M | 25.9 M | 25.3 M | 21.9 M | 20 M | 12.7 M | 9.58 M | 9.13 M | 8.66 M | 4.49 M | 398 K | 15.9 M | - | - | 46.2 K | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 36.8 M | 46.2 K | 18.4 M |
Quarterly Shares Harrow Health
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 37.2 M | 37.1 M | 36.8 M | 35.8 M | 35.6 M | 35.7 M | 35.6 M | 35.5 M | 35.2 M | 34.3 M | 30.5 M | 30.3 M | 29.9 M | 27.3 M | 27.3 M | 27.2 M | 26.9 M | 27.1 M | 26.7 M | 26 M | 25.7 M | 25.9 M | 25.9 M | 25.9 M | 25.5 M | 25.6 M | 25.2 M | 24.8 M | 24.3 M | 21.7 M | 21.2 M | 20.9 M | 20.6 M | 20.3 M | 20.2 M | 18.9 M | 18.6 M | 13.5 M | 13.3 M | 10.4 M | 9.76 M | 9.6 M | 9.5 M | 9.34 M | 9.26 M | 9.15 M | 9.11 M | 9.01 M | 8.97 M | 8.96 M | 8.89 M | 7.79 M | 6.77 M | 6.22 M | 3.87 M | 1.06 M | 398 K | 1.99 M | 1.99 M | 1.99 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 37.2 M | 398 K | 20 M |
Shares of other stocks in the Drug manufacturers industry
| Issuer | Shares | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Endo International plc
ENDP
|
235 M | - | - | $ 28.9 M |  Irlanda |
 |
Evoke Pharma
EVOK
|
1.91 M | - | - | $ 36.6 M |  USA |
 |
HEXO Corp.
HEXO
|
389 M | - | 2.45 % | $ 38.1 M |  Canada |
 |
Calliditas Therapeutics AB (publ)
CALT
|
53.7 M | - | -0.1 % | $ 2.03 B |  Schweden |
 |
AcelRx Pharmaceuticals
ACRX
|
42.4 M | - | 7.5 % | $ 6.35 M | USA |
 |
DURECT Corporation
DRRX
|
30.9 M | - | - | $ 50.1 M | USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
150 M | - | 0.86 % | $ 117 M | USA |
 |
Aerie Pharmaceuticals
AERI
|
46.3 M | - | - | $ 754 M | USA |
 |
Agile Therapeutics
AGRX
|
2.16 M | - | 10.11 % | $ 58.2 M | USA |
 |
Alimera Sciences
ALIM
|
25.6 M | - | - | $ 142 M | USA |
 |
Athenex
ATNX
|
6.54 M | - | -23.39 % | $ 1.76 M | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
95.1 M | - | - | $ 2.06 B |  France |
 |
Catalent
CTLT
|
181 M | - | - | $ 11.5 B | USA |
 |
Eagle Pharmaceuticals
EGRX
|
12.9 M | - | -39.89 % | $ 27.7 M | USA |
 |
Jupiter Wellness
JUPW
|
4.01 M | - | - | $ 33.6 M | USA |
 |
Lannett Company
LCI
|
40.4 M | - | 1.15 % | $ 7.11 M | USA |
 |
Neoleukin Therapeutics
NLTX
|
21.3 M | - | - | $ 193 M | Canada |
 |
Assertio Holdings
ASRT
|
6.4 M | - | - | $ 150 M | USA |
 |
ProPhase Labs
PRPH
|
8.49 M | - | - | $ 5.07 M | USA |
 |
Radius Health
RDUS
|
47.2 M | - | - | $ 1.42 B | USA |
 |
PetIQ
PETQ
|
29.1 M | - | 1.64 % | $ 400 M | USA |
 |
Recro Pharma
REPH
|
95.2 M | - | -4.76 % | $ 65.3 M | USA |
 |
OptiNose
OPTN
|
10.2 M | - | - | $ 1.08 B | USA |
 |
PLx Pharma
PLXP
|
23.7 M | - | -27.8 % | $ 2.56 M | USA |
 |
Zomedica Corp.
ZOM
|
980 M | - | -0.21 % | $ 98 M | USA |
 |
Zynerba Pharmaceuticals
ZYNE
|
42.7 M | - | - | $ 55.5 M | USA |
 |
Tricida
TCDA
|
51.3 M | - | - | $ 3.25 M | USA |
 |
Sundial Growers
SNDL
|
1.86 M | $ 1.42 | -1.39 % | $ 3.37 M | Canada |
 |
Aurora Cannabis
ACB
|
54.8 M | $ 2.93 | 0.34 % | $ 161 M | Canada |
 |
Bausch Health Companies
BHC
|
371 M | $ 4.77 | 0.21 % | $ 1.77 B | Canada |
 |
Canopy Growth Corporation
CGC
|
298 M | $ 0.97 | 2.49 % | $ 289 M | Canada |
 |
China Pharma Holdings
CPHI
|
4.29 M | $ 0.77 | -6.56 % | $ 3.3 M |  China |
 |
Cumberland Pharmaceuticals
CPIX
|
14.9 M | $ 5.72 | 1.96 % | $ 85 M | USA |
 |
Cronos Group
CRON
|
383 M | $ 2.71 | 1.5 % | $ 1.04 B | Canada |
 |
Emergent BioSolutions
EBS
|
53.5 M | $ 8.0 | -1.72 % | $ 428 M | USA |
 |
Evolus
EOLS
|
64.5 M | $ 6.63 | -1.63 % | $ 427 M | USA |
 |
OrganiGram Holdings
OGI
|
95.3 M | $ 0.96 | -2.28 % | $ 91.5 M | Canada |
 |
Organogenesis Holdings
ORGO
|
127 M | $ 2.44 | 4.27 % | $ 309 M | USA |
 |
Pacira BioSciences
PCRX
|
46.2 M | $ 22.33 | -1.37 % | $ 1.03 B | USA |
 |
Perrigo Company plc
PRGO
|
138 M | $ 10.25 | 0.89 % | $ 1.42 B | USA |
 |
Relmada Therapeutics
RLMD
|
39.5 M | $ 6.73 | 1.97 % | $ 266 M | USA |
 |
Rockwell Medical
RMTI
|
36 M | $ 0.64 | -1.61 % | $ 23 M | USA |
 |
SCYNEXIS
SCYX
|
49.9 M | $ 4.05 | 6.58 % | $ 202 M | USA |
 |
Solid Biosciences
SLDB
|
87.5 M | $ 8.33 | 13.95 % | $ 729 M | USA |
 |
Sonoma Pharmaceuticals
SNOA
|
1.68 M | $ 1.15 | - | $ 1.94 M | USA |
 |
Tilray
TLRY
|
618 M | $ 4.73 | -0.42 % | $ 2.92 B | Canada |
 |
TherapeuticsMD
TXMD
|
11.6 M | $ 1.95 | -14.1 % | $ 22.6 M | USA |
 |
Veru
VERU
|
14.6 M | $ 2.95 | -1.34 % | $ 43.2 M | USA |
 |
Viatris
VTRS
|
1.2 B | $ 15.37 | -2.29 % | $ 17.9 B | USA |